Sen, S.; Valindria, V.; Slator, P.J.; Pye, H.; Grey, A.; Freeman, A.; Moore, C.; Whitaker, H.; Punwani, S.; Singh, S.;
et al. Differentiating False Positive Lesions from Clinically Significant Cancer and Normal Prostate Tissue Using VERDICT MRI and Other Diffusion Models. Diagnostics 2022, 12, 1631.
https://doi.org/10.3390/diagnostics12071631
AMA Style
Sen S, Valindria V, Slator PJ, Pye H, Grey A, Freeman A, Moore C, Whitaker H, Punwani S, Singh S,
et al. Differentiating False Positive Lesions from Clinically Significant Cancer and Normal Prostate Tissue Using VERDICT MRI and Other Diffusion Models. Diagnostics. 2022; 12(7):1631.
https://doi.org/10.3390/diagnostics12071631
Chicago/Turabian Style
Sen, Snigdha, Vanya Valindria, Paddy J. Slator, Hayley Pye, Alistair Grey, Alex Freeman, Caroline Moore, Hayley Whitaker, Shonit Punwani, Saurabh Singh,
and et al. 2022. "Differentiating False Positive Lesions from Clinically Significant Cancer and Normal Prostate Tissue Using VERDICT MRI and Other Diffusion Models" Diagnostics 12, no. 7: 1631.
https://doi.org/10.3390/diagnostics12071631
APA Style
Sen, S., Valindria, V., Slator, P. J., Pye, H., Grey, A., Freeman, A., Moore, C., Whitaker, H., Punwani, S., Singh, S., & Panagiotaki, E.
(2022). Differentiating False Positive Lesions from Clinically Significant Cancer and Normal Prostate Tissue Using VERDICT MRI and Other Diffusion Models. Diagnostics, 12(7), 1631.
https://doi.org/10.3390/diagnostics12071631